Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.
Stem Cell Rev Rep. 2022 Jan;18(1):214-227. doi: 10.1007/s12015-021-10224-9. Epub 2021 Aug 4.
Multipotent stromal cells (MSCs) are widely utilized in therapy for their immunomodulatory properties, but their usage in infectious viral diseases is less explored. This review aimed to collate the current novel use of MSCs in virus-associated conditions, including MSC's susceptibility to virus infection, antiviral properties of MSCs and their effects on cell-based immune response and implementation of MSC therapy in animal models and human clinical trials of viral diseases. Recent discoveries shed lights on MSC's capability in suppressing viral replication and augmenting clearance through enhancement of antiviral immunity. MSC therapy may maintain a crucial balance between aiding pathogen clearance and suppressing hyperactive immune response.
多能基质细胞(MSCs)因其免疫调节特性而被广泛应用于治疗,但它们在感染性病毒疾病中的应用研究较少。本综述旨在整理 MSCs 在病毒相关疾病中的最新应用,包括 MSCs 对病毒感染的易感性、MSCs 的抗病毒特性及其对基于细胞的免疫反应的影响,以及 MSCs 治疗在病毒性疾病的动物模型和人体临床试验中的应用。最近的发现揭示了 MSC 通过增强抗病毒免疫来抑制病毒复制和增强清除能力的能力。MSC 治疗可能在帮助清除病原体和抑制过度活跃的免疫反应之间保持着至关重要的平衡。